| BCTXW Stock | | | USD 0.34 0.03 9.68% |
BriaCell Therapeutics financial indicator trend analysis is way more than just evaluating BriaCell Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BriaCell Therapeutics is a good investment. Please check the relationship between BriaCell Therapeutics Accounts Payable and its Cash accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in BriaCell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
Accounts Payable vs Cash
Accounts Payable vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
BriaCell Therapeutics Accounts Payable account and
Cash. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between BriaCell Therapeutics' Accounts Payable and Cash is -0.11. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Cash in the same time period over historical financial statements of BriaCell Therapeutics Corp, assuming nothing else is changed. The correlation between historical values of BriaCell Therapeutics' Accounts Payable and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of BriaCell Therapeutics Corp are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Accounts Payable i.e., BriaCell Therapeutics' Accounts Payable and Cash go up and down completely randomly.
Correlation Coefficient | -0.11 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Accounts Payable
An accounting item on the balance sheet that represents BriaCell Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of BriaCell Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Cash
Cash refers to the most liquid asset of BriaCell Therapeutics, which is listed under current asset account on BriaCell Therapeutics Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from BriaCell Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different BriaCell Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from BriaCell Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BriaCell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in BriaCell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
At this time, BriaCell Therapeutics'
Selling General Administrative is fairly stable compared to the past year.
Issuance Of Capital Stock is likely to climb to about 8.4
M in 2024, whereas
Enterprise Value Over EBITDA is likely to drop
(3.62) in 2024.
BriaCell Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
BriaCell Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BriaCell Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for BriaCell Stock Analysis
When running BriaCell Therapeutics' price analysis, check to
measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to
predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.